Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study

Michael Wang(The University of Texas MD Anderson Cancer Center), M. Lia Palomba(Memorial Sloan Kettering Cancer Center), Tanya Siddiqi(City Of Hope National Medical Center), Scott R. Solomon(Northside Hospital), Leo I. Gordon(Northwestern University), Jon Arnason(Beth Israel Deaconess Medical Center), Ricardo Espinola(Bristol-Myers Squibb (United States)), Amitkumar Mehta(University of Alabama at Birmingham), Alexandre V. Hirayama(Fred Hutch Cancer Center), K. OGASAWARA(Bristol-Myers Squibb (United States)), Charalambos Andreadis(University of California, San Francisco), Nilanjan Ghosh(Levine Cancer Institute), Amy M. Chattin(Bristol-Myers Squibb (United States)), Laurie Eliason(Bristol-Myers Squibb (United States)), Matthew A. Lunning(University of Nebraska Medical Center), Lily Peng(Harvard University), Christine Dehner(Bristol-Myers Squibb (United States)), Manali Kamdar(University of Colorado Cancer Center), Ana Kostić(Columbia University), Jeremy S. Abramson(Harvard University)
Journal of Clinical Oncology
December 11, 2023
Cited by 94


Related Papers